Juergen Beck

Juergen Beck is an accomplished medical professional currently serving as Chief Medical Officer at both Memo Therapeutics AG and PROSION since April 2022. Previously, Beck held the position of Chief Development Officer and Member of the Management Board at PAION AG from January 2018 to December 2020, overseeing product development and regulatory functions. Beck has a robust background in clinical operations, having served as Vice President of Clinical Operations Europe at InterMune and Senior Vice President of Medical Affairs at Epigenomics AG. With a career spanning over three decades, Beck has experience in general management and clinical research at various organizations, including Monitoring Force and Synthélabo, and possesses a strong academic foundation with a degree in medicine and economics from multiple German universities.